Weight loss comparison Clinical research shows significant differences in weight loss outcomes between these medications: Research demonstrates that Saxenda achieves an average weight loss of 6.4%, while studies show Mounjaro can lead to weight loss of up to 25%
This could eventually lead to broad-acting preventative interventions
Combining CJC-1295, a GHRH analog, with Ipamorelin, a GHRP peptide, amplifies your bodys natural ability to restore muscle tone, improve recovery, and enhance energy without synthetic hormones
For many people living with obesity, this level of weight loss is not just cosmetic, it reduces the risk of heart disease, joint pain, improves mobility and boosts quality of life
Having access to a dedicated team means that if a morning dose isnt working for you, you have the professional support to adjust your plan without stress or confusion
The steps to starting are simple: Complete the health assessment to provide your medical background